Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

By J. Kaplan, D. Hanson, M. Dworkin, T. Frederick, J. Bertolli, M. Lindegren, S. Holmberg, Jeffrey L. Jones. Clinical Infectious Diseases, 2000

735 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Toxoplasma gondii infection in humans and animals in the United States. (2008, background): “However, during the years that prophylaxis and highly active antiretroviral therapy became widely used (mid-1990s in most developed countries), the incidence and deaths associated with toxoplasmic encephalitis declined markedly (Jones et al., 1999, 2002; Kaplan et al., 2000; Hooshyar et al., 2007).”
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS (2009, background): “Eleven studies directly reported an estimated incidence and in three [9,13,14] the incidence was determined based on data provided in a figure in the original article.”
Epidemiology of Invasive Mycoses in North America (2010, methodology): “PCP cases declined by 3.4% per year from 1992 through 1995, whereas the rate of decline increased to 21.57% per year from 1996 through 1998 (Kaplan et al. 2000; Morris et al. 2004; Tellez et al. 2008).”